According to a new study published in the journal PLOS One, registered medical marijuana patients who use the medication to treat chronic pain are more likely to reduce or cease use of opioids compared to those who are not enrolled and suffer from similar pain conditions. Researchers from the University of New Mexico analyzed prescription use over the course of 21 months in 37 medical marijuana pain patients and 29 non-registered pain patients. They found 83.8% of medical marijuana patients reduced daily opioid use while 44.8% of non-registered patients reduced daily use. Additionally, 40.5% of medical marijuana patients stopped use completely, while only 3.4% of non-registered patients stopped use. Those who enrolled in medical marijuana programs also reported a better quality of life. The authors concluded, “The clinically and statistically significant evidence of an association between MCP enrollment and opioid prescription cessation and reductions and improved quality of life warrants further investigations on cannabis as a potential alternative to prescription opioids for treating chronic pain.”
This information has been provided by NORML and approved by our Chief Medical Officer.